title: Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections.
abstract: We compared treatment with one daily intravenous dose of cefonicid and multidose nafcillin in 65 patients with severe infections of the skin or skin structure. Clinical cure or improvement was achieved in 91% of the patients given cefonicid and in 87% of the patients given nafcillin (P = 0.97). The use of cefonicid may allow outpatient therapy of some severe infections.
authors.affiliation: Department of Medicine, St. Elizabeth's Hospital, Brighton, Massachusetts 02135.
authors.forename: J S
authors.initials: JS
authors.lastname: Daly
authors.forename: M G
authors.initials: MG
authors.lastname: Worthington
authors.forename: R J
authors.initials: RJ
authors.lastname: Andrews
authors.forename: R B
authors.initials: RB
authors.lastname: Brown
authors.forename: R
authors.initials: R
authors.lastname: Schwartz
authors.forename: D J
authors.initials: DJ
authors.lastname: Sexton
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015790:Cefonicid / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009254:Nafcillin / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D009254:Nafcillin; D015790:Cefonicid